Surveillance of microbial resistance in European Intensive Care Units: A first report from the Care-ICU programme for improved infection control

Intensive Care Medicine

Volumn 35, Issue 1, 2009, Pages 91-100

  Hanberger, Håkan ^a,c   Arman, Dilek ^b   Gill, Hans ^c   Jindrák, Vlastimil ^d   Kalenic, Smilja ^e   Kurcz, Andrea ^f   Licker, Monica ^g   Naaber, Paul ^h   Scicluna, Elizabeth A ⁱ   Vanis, Václav ^d   Walther, Sten M ^c,j,k  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c LINKÖPING UNIVERSITY   (Sweden)

^d NA HOMOLCE HOSPITAL   (Czech Republic)

^e UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^f National Centre for Epidemiologia   (Hungary)

^g VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^h TARTU UNIVERSITY CLINICS   (Estonia)

ⁱ MATER DEI HOSPITAL   (Malta)

^j LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^k ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

Antibiotic consumption; Infection control; Intensive care; Microbial resistance

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIDAZOLE DERIVATIVE; IMIPENEM; OXACILLIN; PENICILLIN G; QUINOLONE DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL INFECTION; DRUG USE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HEALTH PROGRAM; HEALTH SURVEY; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PATIENT ISOLATION; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; SENTINEL SURVEILLANCE;

EID: 58549085963     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-008-1237-y     Document Type: Article

References (36)

1. JL Vincent 2000 Microbial resistance: lessons from the EPIC study European Prevalence of Infection Intensive Care Med 26 suppl 1 S3 S8
2. H Hanberger D Diekema A Fluit R Jones M Struelens R Spencer M Wolff 2001 Surveillance of antibiotic resistance in European ICUs J Hosp Infect 48 161 176
3. A Deplano O Denis L Poirel D Hocquet C Nonhoff B Byl P Nordmann JL Vincent MJ Struelens 2005 Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa J Clin Microbiol 43 1198 1204
4. JL Vincent Y Sakr CL Sprung VM Ranieri K Reinhart H Gerlach R Moreno J Carlet JR Le Gall D Payen 2006 Sepsis in European intensive care units: results of the SOAP study Crit Care Med 34 344 353
5. MM Wroblewska J Rudnicka H Marchel M Luczak 2006 Multidrug-resistant bacteria isolated from patients hospitalised in intensive care units Int J Antimicrob Agents 4 285 289
6. P Gastmeier D Sohr C Geffers M Behnke H Ruden 2007 Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infektions Surveillance System Infect Control Hosp Epidemiol 4 466 472
7. H Hanberger LG Burman O Cars M Erlandsson H Gill LE Nilsson D Nordlinder SM Walther ICU STRAMA Study Group 2007 Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period Acta Anaesthesiol Scand 51 937 941
8. M Tato TM Coque P Ruíz-Garbajosa V Pintado J Cobo HS Sader RN Jones F Baquero R Cantón 2007 Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis 45 1171 1178
9. P Damas D Ledoux M Nys M Monchi P Wiesen B Beauve JC Preiser 2008 Intensive care unit acquired infection and organ failure Intensive Care Med 34 856 864
10. Brun-Buisson C (2008) ICU-acquired infections and sepsis: more of a deadly duo. Intensive Care Med 34:793-795
11. DL Monnet 2000 Toward multinational antimicrobial resistance surveillance systems in Europe Int J Antimicrob Agents 15 91 101
12. Hanberger H, Arman D, Gill H, Kalenic S, Naaber P, Scicluna E, Suetens C (2008) CARE-ICU-Controlling Antibiotic REsistance in Intensive Care Units-First report from a web-based program for improved infection control in European ICUs. In: Programme of the 18th European congress of clinical microbiology and infectious diseases, Barcelona
13. 90 as a novel index of susceptibility Scand J Infect Dis 36 24 30
14. Hanberger H, Monnet DL, Nilsson LE (2005) Intensive care unit. In: Gould I, van der Meer J (eds) Antibiotic policies. Theory and practice. Kluwer Academic/Plenum Publishers, New York, pp 261-271
15. M Erlandsson LG Burman O Cars H Gill LE Nilsson SM Walther H Hanberger the STRAMA ICU Study Group 2007 Prescription of antibiotic agents in Swedish intensive care units is empiric and precise Scand J Infect Dis 39 63 69
16. K de With J Bergner R Buhner K de With J Bergner R Bühner F Dörje C Gonnermann M Haber M Hartmann U Rothe E Strehl M Steib-Bauert WV Kern 2004 Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II) Int J Antimicrob Agents 24 213 221
17. A Muller DL Monnet D Talon T Hénon X Bertrand 2006 Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital Br J Clin Pharmacol 61 585 591
18. E Meyer F Schwab P Gastmeier H Rueden FD Daschner D Jonas 2006 Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units) J Hosp Infect 64 238 243
19. JM Loeffler J Garbino D Lew S Harbarth P Rohner 2003 Antibiotic consumption, bacterial resistance and their correlation in a Swiss University Hospital and its adult intensive care units Scand J Infect Dis 35 843 850
20. SW Lemmen H Häfner S Kotterik R Lütticken R Töpper 2000 Influence of an infectious disease service on antibiotic prescription behaviour and selection of multiresistant pathogens Infection 28 384 387
21. Monnet DL SC, Jepsen OB (2000) Overall antimicrobial use and control strategies in intensive care units from 6 European countries. Abstract; 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections. CDC/SHEA, Atlanta
22. DA Goldmann RA Weinstein RP Wenzel OC Tablan RJ Duma RP Gaynes J Schlosser WJ Martone 1996 Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership JAMA 275 234 240
23. I Björholt E Haglind 2004 Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital Eur J Clin Microbiol Infect Dis 23 688 695
24. Lucet J-C, Paoletti X, Lolom I, Paugam-Burtz C, Trouillet J-L, Timsit J-F, Deblangy C, Andremont A, Regnier B (2005) Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 31:1051-1057
25. E Raineri L Crema A De Silvestri A Acquarolo F Albertario G Carnevale N Latronico N Petrosillo C Tinelli A Zoncada A Pan 2007 Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis J Hosp Infect 67 308 315
26. E Nulens E Broex A Ament RH Deurenberg E Smeets J Scheres FH van Tiel B Gordts EE Stobberingh 2008 Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital J Hosp Infect 68 301 307
27. S Harbarth C Fankhauser J Schrenzel J Christenson P Gervaz C Bandiera-Clerc G Renzi N Vernaz H Sax D Pittet 2008 Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients JAMA 299 1149 1157
28. JA Cepeda T Whitehouse B Cooper J Hails K Jones F Kwaku L Taylor S Hayman B Cookson S Shaw C Kibbler M Singer G Bellingan AP Wilson 2005 Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study Lancet 365 295 304
29. H Humphreys 2008 Can we do better in controlling and preventing methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU)? Eur J Clin Microbiol Infect Dis 27 409 413 Feb 13 (Epub ahead of print)
30. D Landman S Bratu M Alam J Quale 2005 Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B J Antimicrob Chemother 55 954 957
31. ME Falagas IA Bliziotis 2007 Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29 630 636
32. D Jonas E Meyer F Schwab H Grundmann 2008 Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units Infect Control Hosp Epidemiol 29 350 357
33. Y Carmeli N Troillet GM Eliopoulos MH Samore 1999 Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different anti-pseudomonal agents Antimicrob Agents Chemother 43 1379 1382
34. C Peña A Guzmán C Suarez MA Dominguez F Tubau M Pujol F Gudiol J Ariza 2007 Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients Antimicrob Agents Chemother 51 1967 1971
35. Erlandsson M, Gill H, Nilsson LE, Giske, Jonas, Nordlinder D, Walther SM, Hanberger H (2008) Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa from patients in Swedish ICUs. Scand J Infect Dis 40:487-494
36. MJ Bonten RA Weinstein 2006 Antibiotic cycling in intensive care units: the value of organized chaos? Crit Care Med 34 549 551